Haemonetics Corporation (HAE)
Chart Events
Performance Outlook
| Previous Close | 43.77 |
| Open | 43.55 |
| Bid | 44.15 x 900 |
| Ask | 44.11 x 800 |
| Day's Range | 43.51 - 44.95 |
| 52 Week Range | 43.51 - 142.11 |
| Volume | |
| Avg. Volume | 526,130 |
| Market Cap | 2.256B |
| Beta (5Y Monthly) | 0.27 |
| PE Ratio (TTM) | 73.33 |
| EPS (TTM) | 0.60 |
| Earnings Date | Jan 31, 2022 - Feb 04, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 73.13 |
- PR Newswire
Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2022 Results: February 8, 2022
Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish third quarter fiscal year 2022 financial results at 6:00 am EST on Tuesday, February 8, 2022. The Company will hold a conference call with investors and analysts to discuss results and answer questions at 8:00 am EST on February 8, 2022.
- GuruFocus.com
Managed Portfolio Series Buys Haemonetics Corp, Sprouts Farmers Market Inc, Patterson Inc, ...
Investment company Managed Portfolio Series (Current Portfolio) buys Haemonetics Corp, Sprouts Farmers Market Inc, Patterson Inc, TripAdvisor Inc, Frontdoor Inc, sells Healthcare Services Group Inc, Jefferies Financial Group Inc, Urban Outfitters Inc, Jones Lang LaSalle Inc, Gildan Activewear Inc during the 3-months ended 2021Q3, according to the most recent filings of the investment company, Managed Portfolio Series.
- Zacks
Here's Why You Should Retain Haemonetics (HAE) Stocks for Now
Investors are optimistic about Haemonetics (HAE) on a strong recovery across businesses, mainly at Hospital, and the initial Plasma Persona rollouts.
